/
/
IMMUPARKNET Training School 2 – Immune Profiling in Parkinson’s Disease

IMMUPARKNET Training School 2 – Immune Profiling in Parkinson’s Disease

Seville, 9–10 April 2026

The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain, focusing on immune profiling in Parkinson’s disease and the design of observational clinical studies.

The event was hosted by Prof. Pablo Mir and Dr. Laura Muñoz, bringing together clinicians, neurologists, and translational researchers with the shared goal of strengthening methodological skills for investigating the role of the immune system in Parkinson’s disease.

A multidisciplinary training experience

The main objective of the Training School was to equip participants with the knowledge and practical tools needed to design and conduct robust observational studies exploring immune mechanisms in Parkinson’s disease.

Key topics included:

  • inclusion and exclusion criteria for study participants
  • study design (cross-sectional vs. longitudinal approaches)
  • clinical phenotyping and patient stratification
  • biological samples and immune biomarkers
  • neuroimaging and markers of neuroinflammation

The program strongly promoted an interdisciplinary approach, fully aligned with the goals of the IMMUPARKNET COST Action CA21117, which also supported travel and per diem reimbursement for selected participants.


A collaborative learning environment

Flash presentations and hands-on methodological discussions allowed participants to refine their study designs and foster new international collaborations within the IMMUPARKNET network.


The IMMUPARKNET Training School 2 provided an intensive and highly collaborative learning experience at the intersection of neurology, immunology, and translational research.

It reinforced the importance of standardized and well-designed observational studies to better understand immune mechanisms in Parkinson’s disease.

📸 Group photo of all participants of the second IMMUPARKNET Training School at IBiS, Spain.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

Article wordpress

A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...

ChatGPT Image 25 gen 2026, 03_00_53

We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...

328ec109-a3d1-4ef6-84fd-795b242d1f3d

We are pleased to announce that the call for grant applications for Grant Period 4 of ImmuParkNet is now open. This call covers activities to...

Infografica - Gender Equality Initiative

COST Action IMMUPARKNET is pleased to present its Gender Equality Plan (GEP) 2025, a strategic document that reflects on the progress made and sets out...

Training School

We are pleased to invite you to the upcoming IMMUPARKNET Training School on Immune Profiling in Parkinson’s Disease: Designing Observational Clinical Studies Venue: Instituto de...

WhatsApp Image 2025-11-24 at 13.57.20

On the past 17-19 October 2025, members of IMMUPARKNET COST Action met at the The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus, to discuss...